DECCAN HEALTH CARE LIMITED BSE SME IPO TO OPEN ON DECEMBER 18, 2018
WITH PRICE BAND OF RS. 95 TO RS. 100 PER EQUITY SHARE OF FACE VALUE OF RS. 10 EACH
· THE INITIAL PUBLIC OFFERING OF 42,12,000 EQUITY SHARES AGGREGATING RS. 42.12 CRORES (AT CAP PRICE)
· THE IPO CONSISTS OF FRESH ISSUE OF 22,12,000 EQUITY SHARES AGGREGATING RS. 22.12 CRORES (AT CAP PRICE)
· THE IPO CONSISTS OF OFFER FOR SALE OF 20,00,000 EQUITY SHARES AGGREGATING RS. 20.00 CRORES (AT CAP PRICE)
· THE MINIMUM BID LOT IS 1,200 EQUITY SHARES AND IN MULTIPLES OF 1,200 EQUITY SHARES THEREAFTER.
· OFFER OPENING DATE – DECEMBER 18, 2018 AND OFFER CLOSING DATE – DECEMBER 20, 2018

The Initial Public Offering of 42,12,000 Equity Shares of face value of 10/-each aggregating to Rs 4,212.00* lakhs (“offer”) comprising a fresh issue of 22,12,000 equity shares aggregating to Rs. 2,212.00* lakhs by the company (“fresh issue”) and an offer for sale of 14,00,000 equity shares by Hitesh Patel (referred to as the “ promoter selling shareholder) and 6,00,000 equity shares by Meenakshi Gupta (referred to as the “selling shareholder”) aggregating 20,00,000 equity shares by the selling shareholders (“offer for sale”) and together with the fresh issue (“the offer”).



In terms of SEBI Circular No. CIR/CFD/POLICYCELL/11/2015, all potential investors shall participate in the Offer only through an Application Supported by Blocked Amount (“ASBA”) process providing details about the bank account which will be blocked by the Self Certified Syndicate Banks (“SCSBs”) for the same.
Pantomath Capital Advisors Private Limited is the Book Running Lead Manager to the issue and Bigshare Services Private Ltd is the Registrar to the Issue. The Equity Shares of Deccan Health Care Limited are proposed to be listed on SME Platform of BSE Limited.
*Calculated on the cap price
ReplyDeleteAbsolutely thrilled to see the recent developments in the SME IPO Listing! This is a fantastic opportunity for small and medium enterprises to gain visibility and access capital, fueling their growth and innovation.
As
ReplyDeletetransaction valuation firm, Transique Advisors often encounters similar nuances in cross-border valuation and classification during M&A and strategic advisory engagements.